evenfolioETF Details
VanEck·Health·TRUH · Nasdaq
VanEck Healthcare TruSector ETF (TRUH)
- Price
- $32.78
- —12 Nov 2026
- Assets
- $640,000
- Total net assets
- Expense ratio
- 0.10%
- Category 1.00%
- Yield
- —
- Trailing distributions
- 1Y return
- —
- Category 23.8%
- 3Y CAGR
- —
- Category 20.2%
- 5Y CAGR
- —
- Category 3.9%
$32.78—12 Nov 2026
Fund
- Assets
- $640,000
- Expense
- 0.10%
- Categ. exp
- 1.00%
- Yield
- —
ReturnFundCateg.
1Y—23.8%
3Y—20.2%
5Y—3.9%
Launch29.1%—
Loading NAV history…
VanEck Healthcare TruSector ETF
Calendar-year returns
Fund only: no comparison series covers this fund's history.
Risk statistics
Five years of daily closes. Risk-free rate 4% a year.
- Standard deviation
- —
- Maximum drawdown
- —
- Sharpe ratio
- —
- Sortino ratio
- —
- Beta
- —
- Alpha
- —
- R²
- —
- Information ratio
- —
- Upside capture
- —
- Downside capture
- —
- Tracking error
- —
| Period | 1M | 3M | 6M | YTD | 1Y | 3YCAGR | 5YCAGR | 10YCAGR | LaunchCAGR |
|---|---|---|---|---|---|---|---|---|---|
| ETF | +10.7% | +12.1% | +29.2% | — | — | — | — | — | +29.1% |
| Health average | 6.4% | 4.0% | 21.1% | 20.0% | 23.8% | 20.2% | 3.9% | 10.1% | 11.2% |
| Difference | +4.3% | +8.1% | +8.1% | — | — | — | — | — | +17.9% |
Holdings
The 10 largest positions make up 60.9% of the fund.
Top holdings
| Ticker | Holding | Weight |
|---|---|---|
| LLY | Eli Lilly and Co | 15.27% |
| JNJ | Johnson & Johnson | 10.44% |
| ABBV | AbbVie Inc | 7.54% |
| MRK | Merck & Co Inc | 5.95% |
| UNH | UnitedHealth Group Inc | 5.46% |
| TMO | Thermo Fisher Scientific Inc | 4.10% |
| AMGN | Amgen Inc | 3.69% |
| GILD | Gilead Sciences Inc | 3.04% |
| ABT | Abbott Laboratories | 2.82% |
| PFE | Pfizer Inc | 2.64% |
Portfolio valuation
Weighted averages of what the fund holds.
- P/E
- 30.1
- P/B
- 4.8
- P/S
- 1.7
- P/CF
- 17.9
Sector allocation
Share of the equity the fund holds.
- Health care100.0%
Asset mix
- Stocks99.9%
- Cash0.1%
ETF details
- Issuer
- VanEck
- Category
- Equity · Health
- Ticker
- TRUH
- Exchange
- Nasdaq
- Inception
- 1 Apr 2026 (0.6 years)
- Structure
- Exchange Traded Fund
- Expense ratio
- 0.10% (category 1.00%)
- Holdings turnover
- 0% (category 51%)
- Distribution yield
- —
- Beta, 3 years
- 0.00
- Total net assets
- $640,000
Prices and returns as of 12 Nov 2026; total return with distributions reinvested, before brokerage and taxes. Not investment advice.
Other health ETFs
Other ETFs in the Health category.
- XLV · State Street Health Care Select Sector SPDR ETFState Street Investment Management · $49.1B · ER 0.08%5Y 8.8%
- VHT · Vanguard Health Care ETFVanguard · $21.8B · ER 0.09%5Y 7.6%
- IBB · iShares Biotechnology ETFiShares · $11.5B · ER 0.44%5Y 7.0%
- XBI · State Street SPDR S&P Biotech ETFState Street Investment Management · $10.9B · ER 0.35%5Y 3.8%
- IXJ · iShares Global Healthcare ETFiShares · $4.6B · ER 0.38%5Y 7.0%
- IYH · iShares U.S. Healthcare ETFiShares · $4B · ER 0.37%5Y 7.6%